Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein U-like protein 2 (HNRNPUL2)

Target
HNRNPUL2
Molecular classification
RNA binding protein, Nuclear protein, Other
01

Overview

Heterogeneous nuclear ribonucleoprotein U-like protein 2 (HNRNPUL2) is a nuclear RNA-binding protein that participates in alternative mRNA splicing, associates with chromatin, and plays a regulatory role in DNA damage repair through modulation of topoisomerase II activity[1][3][6][7]. It is localized mainly in the nucleoplasm and is dynamically associated with chromatin depending on cellular conditions[3][5][6]. HNRNPUL2 interacts with regulators of DNA topology and is rapidly recruited to the nucleus and regions of DNA damage, where its expression correlates with resistance to DNA double-strand breakage and enhanced DNA repair capacity[1]. Although closely related proteins in the hnRNP family are implicated in neurodevelopmental and other disorders, there are no current drug therapies targeting HNRNPUL2, nor is it recognized as a therapeutic receptor, enzyme, or transporter[3][6][7]. Its precise function extends to the maintenance of genomic stability, and its biological roles likely interface at the crossroads of RNA processing and DNA integrity maintenance[1].

Other names
HNRPUL2SAF-A2DKFZp762N1910Scaffold-attachment factor A2MANP (Mlf1-associated nuclear protein)hnRNPUL2heterogeneous nuclear ribonucleoprotein U-like protein 2
02

Biological functions

Alternative mRNA splicing (via spliceosome)RNA bindingChromatin association/bindingDNA damage response and repairRegulation of topoisomerase II activityRegulation of cell cycle and proliferationModulation of gene expression (and potential transcriptional regulation)
03

Disease associations

Neurodevelopmental disorders (by analogy to paralog HNRNPU, no specific disease for HNRNPUL2 identified)Other (no robust evidence for direct involvement in cancer, inflammation, etc. as of 2024)
04

Safety considerations

Potential impact on genome integrity and cell proliferation via effects on DNA repair pathways (theoretical, not clinically validated)No known safety liabilities as a drug target, since it is not currently targeted therapeutically

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein U-like protein 2 (HNRNPUL2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein U-like protein 2 (HNRNPUL2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call